Quanex Building Products Corporation (NYSE:NX)
(“Quanex” or the “Company”) today announced its results for the
three months ended July 31, 2022.
The Company reported the following selected
financial results:
|
Three Months Ended July 31, |
|
Nine Months Ended July, 31 |
($ in millions, except per share data) |
2022 |
|
2021 |
|
2022 |
|
2021 |
Net
Sales |
$324.0 |
|
$279.9 |
|
$914.0 |
|
$780.4 |
Gross
Margin |
$72.6 |
|
$60.0 |
|
$201.0 |
|
$175.7 |
Gross Margin % |
22.4% |
|
21.4% |
|
22.0% |
|
22.5% |
Net
Income |
$25.9 |
|
$13.6 |
|
$63.7 |
|
$36.0 |
Diluted
EPS |
$0.78 |
|
$0.41 |
|
$1.91 |
|
$1.08 |
|
|
|
|
|
|
|
|
Adjusted Net
Income |
$26.2 |
|
$14.2 |
|
$64.0 |
|
$37.8 |
Adjusted
Diluted EPS |
$0.79 |
|
$0.42 |
|
$1.92 |
|
$1.13 |
Adjusted
EBITDA |
$44.2 |
|
$32.9 |
|
$113.8 |
|
$89.5 |
Adjusted EBITDA Margin % |
13.6% |
|
11.8% |
|
12.5% |
|
11.5% |
|
|
|
|
|
|
|
|
Cash
Provided by Operating Activities |
$51.7 |
|
$18.5 |
|
$49.9 |
|
$47.4 |
Free Cash
Flow |
$46.0 |
|
$12.3 |
|
$30.4 |
|
$31.4 |
(See Non-GAAP Terminology Definitions and Disclaimers section,
Non-GAAP Financial Measure Disclosure table, Selected Segment Data
table and Free Cash Flow Reconciliation table for additional
information)
George Wilson, President and Chief Executive
Officer, stated, “We are proud of the results we posted for the
third quarter, especially considering the ongoing inflationary
challenges and macro-related uncertainties. Demand for our products
held up nicely for most of the third quarter and results reflected
the benefit from our pass-through pricing strategy; however, we did
start to experience some softness in demand in Europe towards the
end of July.
“Free Cash Flow increased significantly during
the third quarter of this year compared to the same period last
year. The improvement in Free Cash Flow was driven by a meaningful
increase in net income. We were able to repay $25 million of bank
debt and repurchase $5 million of our common stock during the
quarter. Overall, our balance sheet and liquidity remain strong. We
will continue to focus on generating cash, maintaining a healthy
balance sheet, opportunistically repurchasing our stock and
evaluating growth opportunities.” (See Non-GAAP Terminology
Definitions and Disclaimers section and the reconciliation of Free
Cash Flow to cash provided by operating activities for additional
information)
Third Quarter 2022 Results Summary
Quanex reported net sales of $324.0 million
during the three months ended July 31, 2022, which represents
growth of 15.8% compared to $279.9 million for the same period of
2021. The increase was mostly attributable to higher prices related
to the pass through of raw material cost inflation. More
specifically, the Company realized net sales growth of 25.0% in its
North American Fenestration segment, 17.0% in its North American
Cabinet Components segment and 8.7% in its European Fenestration
segment, excluding the foreign exchange impact. (See Sales Analysis
table for additional information)
The increase in earnings for the three months
ended July 31, 2022 was largely due to increased pricing and
surcharges related to the pass through of raw material cost
inflation and higher volumes in the North American Fenestration
segment.
Balance Sheet & Liquidity
Update
As of July 31, 2022, Quanex had total debt of
$38.0 million and its leverage ratio of Net Debt to LTM Adjusted
EBITDA improved to 0.1x. (See Non-GAAP Terminology
Definitions and Disclaimers section for additional information)
The Company’s liquidity increased to $332.0
million as of July 31, 2022, consisting of $50.0 million in cash on
hand plus availability under its new Amended and Restated Senior
Secured Revolving Credit Facility due 2027, less letters of credit
outstanding.
Share Repurchases
Quanex’s Board authorized a $75 million share
repurchase program in December of 2021. Repurchases under this
program will be made in open market transactions or privately
negotiated transactions, subject to market conditions, applicable
legal requirements, and other relevant factors. The Company
repurchased 216,000 shares of common stock for approximately $5.0
million at an average price of $23.29 per share during the three
months ended July 31, 2022. As of July 31, 2022, approximately
$68.4 million remained under the existing share repurchase
authorization.
Outlook
Mr. Wilson commented, “We are reaffirming
guidance for fiscal 2022, which is based on our strong results
year-to-date coupled with ongoing conversations with our customers.
Overall, demand for our products is still relatively healthy, but
in addition to the softness in Europe we are starting to see signs
of softness in North America, mainly in our cabinet components
business. For the fourth quarter of this year, we now expect ~15%
revenue growth in our North American Fenestration segment and
low-single digit revenue growth in our North American Cabinet
Components segment. Due to continued softness in Europe and the
foreign exchange impact, we expect revenue to decline by ~15% in
our European Fenestration segment in the fourth quarter. As a
reminder, on a consolidated basis, we guided to net sales of $1.18
billion to $1.2 billion, which we expect will generate
approximately $150 million to $155 million in Adjusted EBITDA* in
fiscal 2022.
Longer-term, the underlying fundamentals remain
positive for the residential housing industry in North America and
in the markets we serve in Europe. Our balance sheet is strong and
we are well-positioned to weather any storm, and we are also
prepared to execute on our plan and create further value for
shareholders over time.”
*When Quanex provides expectations for Adjusted
EBITDA on a forward-looking basis, a reconciliation of the
differences between the non-GAAP expectations and corresponding
GAAP measures is generally not available without unreasonable
effort. Certain items required for such a reconciliation are
outside of the Company’s control and/or cannot be reasonably
predicted or estimated, such as the provision for income taxes.
Conference Call and Webcast
Information
The Company has also scheduled a conference call
for Friday, September 2, 2022 at 11:00 a.m. ET (10:00 a.m. CT) to
discuss the release. A link to the live audio webcast will be
available on Quanex’s website at http://www.quanex.com in the
Investors section under Presentations & Events.
Participants can pre-register for the conference call using the
following link:
https://register.vevent.com/register/BIe64ac12abde44f549078e7b4a916e837
Registered participants will receive an email
containing conference call details for dial-in options. To avoid
delays, it is recommended that participants dial into the
conference call ten minutes ahead of the scheduled start time. A
replay will be available for a limited time on the Company’s
website at http://www.quanex.com in the Investors section under
Presentations & Events.
About Quanex
Quanex Building Products Corporation is an
industry-leading manufacturer of components sold to Original
Equipment Manufacturers (OEMs) in the building products
industry. Quanex designs and produces energy-efficient
fenestration products in addition to kitchen and bath cabinet
components. For more information contact Scott Zuehlke,
Senior Vice President, Chief Financial Officer & Treasurer, at
713-877-5327 or scott.zuehlke@quanex.com.
Non-GAAP Terminology Definitions and
Disclaimers
Adjusted Net Income (defined as net income
further adjusted to exclude purchase price accounting inventory
step-ups, transaction costs, certain severance charges, gain/loss
on the sale of certain fixed assets, restructuring charges, asset
impairment charges, other net adjustments related to foreign
currency transaction gain/loss and effective tax rates reflecting
impacts of adjustments on a with and without basis) and Adjusted
EPS are non-GAAP financial measures that Quanex believes provide a
consistent basis for comparison between periods and more accurately
reflects operational performance, as they are not influenced by
certain income or expense items not affecting ongoing operations.
EBITDA (defined as net income or loss before interest, taxes,
depreciation and amortization and other, net) and Adjusted EBITDA
(defined as EBITDA further adjusted to exclude purchase price
accounting inventory step-ups, transaction costs, certain severance
charges, gain/loss on the sale of certain fixed assets,
restructuring charges and asset impairment charges) are non-GAAP
financial measures that the Company uses to measure operational
performance and assist with financial decision-making. Net
Debt is defined as total debt (outstanding balance on the revolving
credit facility plus financial lease obligations) less cash and
cash equivalents. The leverage ratio of Net Debt to LTM Adjusted
EBITDA is a financial measure that the Company believes is useful
to investors and financial analysts in evaluating Quanex’s
leverage. In addition, with certain limited adjustments, this
leverage ratio is the basis for a key covenant in the Company’s
credit agreement. Free Cash Flow is a non-GAAP measure calculated
using cash provided by operating activities less capital
expenditures. Quanex uses the Free Cash Flow metric to measure
operational and cash management performance and assist with
financial decision-making. Free Cash Flow is measured before
application of certain contractual commitments (including capital
lease obligations), and accordingly is not a true measure of the
Company’s residual cash flow available for discretionary
expenditures. Quanex believes Free Cash Flow is useful to investors
in understanding and evaluating the Company’s financial and cash
management performance. Quanex believes that the presented non-GAAP
measures provide a consistent basis for comparison between periods
and will assist investors in understanding the Company’s financial
performance when comparing results to other investment
opportunities. The presented non-GAAP measures may not be the
same as those used by other companies. Quanex does not intend for
this information to be considered in isolation or as a substitute
for other measures prepared in accordance with U.S. GAAP.
Forward Looking Statements
Statements that use the words “estimated,”
“expect,” “could,” “should,” “believe,” “will,” “might,” or similar
words reflecting future expectations or beliefs are forward-looking
statements. The forward-looking statements include, but are not
limited to, the following: impacts from public health issues
(including pandemics, such as the recent COVID-19 pandemic) on the
economy and the demand for Quanex’s products, the Company’s future
operating results, future financial condition, future uses of cash
and other expenditures, expenses and tax rates, expectations
relating to Quanex’s industry, and the Company’s future growth,
including any guidance discussed in this press release. The
statements and guidance set forth in this release are based on
current expectations. Actual results or events may differ
materially from this release. For a complete discussion of factors
that may affect Quanex’s future performance, please refer to the
Company’s Annual Report on Form 10-K for the fiscal year ended
October 31, 2021, and the Company’s Quarterly Reports on Form 10-Q
under the sections entitled “Cautionary Note Regarding
Forward-Looking Statements” and “Risk Factors”. Any forward-looking
statements in this press release are made as of the date hereof,
and Quanex undertakes no obligation to update or revise any
forward-looking statements to reflect new information or
events.
|
|
|
|
|
|
|
|
|
|
|
CONDENSED
CONSOLIDATED STATEMENTS OF INCOME |
(In thousands,
except per share data) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended July 31, |
|
Nine Months Ended July, 31 |
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
324,037 |
|
|
$ |
279,877 |
|
|
$ |
913,970 |
|
|
$ |
780,381 |
|
Cost of
sales |
|
|
251,446 |
|
|
|
219,866 |
|
|
|
712,931 |
|
|
|
604,723 |
|
Selling,
general and administrative |
|
|
28,822 |
|
|
|
27,766 |
|
|
|
87,774 |
|
|
|
88,299 |
|
Restructuring charges |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
39 |
|
Depreciation
and amortization |
|
|
9,734 |
|
|
|
10,683 |
|
|
|
30,554 |
|
|
|
32,543 |
|
Operating
income |
|
|
34,035 |
|
|
|
21,562 |
|
|
|
82,711 |
|
|
|
54,777 |
|
Interest
expense |
|
|
(724 |
) |
|
|
(597 |
) |
|
|
(1,849 |
) |
|
|
(1,988 |
) |
Other,
net |
|
|
398 |
|
|
|
188 |
|
|
|
905 |
|
|
|
645 |
|
Income
before income taxes |
|
|
33,709 |
|
|
|
21,153 |
|
|
|
81,767 |
|
|
|
53,434 |
|
Income tax
expense |
|
|
(7,801 |
) |
|
|
(7,474 |
) |
|
|
(18,098 |
) |
|
|
(17,352 |
) |
Net
income |
|
$ |
25,908 |
|
|
$ |
13,679 |
|
|
$ |
63,669 |
|
|
$ |
36,082 |
|
|
|
|
|
|
|
|
|
|
Earnings per
common share, basic |
|
$ |
0.79 |
|
|
$ |
0.41 |
|
|
$ |
1.92 |
|
|
$ |
1.09 |
|
Earnings per
common share, diluted |
|
$ |
0.78 |
|
|
$ |
0.41 |
|
|
$ |
1.91 |
|
|
$ |
1.08 |
|
|
|
|
|
|
|
|
|
|
Weighted
average common shares outstanding: |
|
|
|
|
|
|
|
|
Basic |
|
|
32,999 |
|
|
|
33,359 |
|
|
|
33,093 |
|
|
|
33,194 |
|
Diluted |
|
|
33,173 |
|
|
|
33,650 |
|
|
|
33,256 |
|
|
|
33,518 |
|
|
|
|
|
|
|
|
|
|
Cash
dividends per share |
|
$ |
0.08 |
|
|
$ |
0.08 |
|
|
$ |
0.24 |
|
|
$ |
0.24 |
|
|
|
|
|
|
|
|
|
|
|
QUANEX
BUILDING PRODUCTS CORPORATION |
CONDENSED
CONSOLIDATED BALANCE SHEETS |
(In thousands) |
(Unaudited) |
|
|
|
|
|
|
|
July 31, 2022 |
|
October 31, 2021 |
ASSETS |
|
|
|
|
Current
assets: |
|
|
|
|
Cash and cash equivalents |
|
$ |
50,030 |
|
|
$ |
40,061 |
|
Accounts receivable, net |
|
|
109,467 |
|
|
|
108,309 |
|
Inventories, net |
|
|
138,237 |
|
|
|
92,529 |
|
Prepaid and other current assets |
|
|
8,651 |
|
|
|
8,148 |
|
Total current assets |
|
|
306,385 |
|
|
|
249,047 |
|
Property,
plant and equipment, net |
|
|
175,404 |
|
|
|
178,630 |
|
Operating
lease right-of-use assets |
|
|
45,722 |
|
|
|
52,708 |
|
Goodwill |
|
|
141,249 |
|
|
|
149,205 |
|
Intangible
assets, net |
|
|
69,670 |
|
|
|
82,410 |
|
Other
assets |
|
|
5,177 |
|
|
|
5,323 |
|
Total assets |
|
$ |
743,607 |
|
|
$ |
717,323 |
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
Current
liabilities: |
|
|
|
|
Accounts payable |
|
$ |
84,527 |
|
|
$ |
86,765 |
|
Accrued liabilities |
|
|
51,453 |
|
|
|
56,156 |
|
Income taxes payable |
|
|
13,709 |
|
|
|
6,038 |
|
Current maturities of long-term debt |
|
|
1,070 |
|
|
|
846 |
|
Current operating lease liabilities |
|
|
7,972 |
|
|
|
8,196 |
|
Total current liabilities |
|
|
158,731 |
|
|
|
158,001 |
|
Long-term
debt |
|
|
55,458 |
|
|
|
52,094 |
|
Noncurrent
operating lease liabilities |
|
|
38,768 |
|
|
|
45,367 |
|
Deferred
pension and postretirement benefits |
|
|
4,498 |
|
|
|
4,737 |
|
Deferred
income taxes |
|
|
21,086 |
|
|
|
21,965 |
|
Other
liabilities |
|
|
14,929 |
|
|
|
15,377 |
|
Total liabilities |
|
|
293,470 |
|
|
|
297,541 |
|
Stockholders’ equity: |
|
|
|
|
Common stock |
|
|
373 |
|
|
|
373 |
|
Additional paid-in-capital |
|
|
251,359 |
|
|
|
254,162 |
|
Retained earnings |
|
|
315,471 |
|
|
|
259,718 |
|
Accumulated other comprehensive loss |
|
|
(41,365 |
) |
|
|
(21,770 |
) |
Treasury stock at cost |
|
|
(75,701 |
) |
|
|
(72,701 |
) |
Total stockholders’ equity |
|
|
450,137 |
|
|
|
419,782 |
|
Total liabilities and stockholders' equity |
|
$ |
743,607 |
|
|
$ |
717,323 |
|
|
|
|
|
|
|
QUANEX
BUILDING PRODUCTS CORPORATION |
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOW |
(In thousands) |
(Unaudited) |
|
|
|
|
|
Nine Months Ended July, 31 |
|
2022 |
|
2021 |
Operating activities: |
|
|
|
Net income |
$ |
63,669 |
|
|
$ |
36,082 |
|
Adjustments to reconcile net income to cash provided by operating
activities: |
|
|
|
Depreciation and amortization |
|
30,554 |
|
|
|
32,543 |
|
Stock-based compensation |
|
1,707 |
|
|
|
1,470 |
|
Deferred income tax |
|
505 |
|
|
|
5,429 |
|
Other, net |
|
2,647 |
|
|
|
5,485 |
|
Changes in assets and liabilities: |
|
|
|
Increase in accounts receivable |
|
(5,306 |
) |
|
|
(8,277 |
) |
Increase in inventory |
|
(48,280 |
) |
|
|
(32,113 |
) |
Increase in other current assets |
|
(824 |
) |
|
|
(2,768 |
) |
Increase in accounts payable |
|
2,765 |
|
|
|
1,600 |
|
(Decrease) increase in accrued liabilities |
|
(4,721 |
) |
|
|
12,521 |
|
Increase (decrease) in income taxes payable |
|
7,522 |
|
|
|
(5,158 |
) |
Decrease in deferred pension and postretirement benefits |
|
(239 |
) |
|
|
(158 |
) |
Increase in other long-term liabilities |
|
32 |
|
|
|
962 |
|
Other, net |
|
(177 |
) |
|
|
(183 |
) |
Cash
provided by operating activities |
|
49,854 |
|
|
|
47,435 |
|
Investing activities: |
|
|
|
Capital expenditures |
|
(19,488 |
) |
|
|
(16,006 |
) |
Proceeds from disposition of capital assets |
|
134 |
|
|
|
3,138 |
|
Cash used
for investing activities |
|
(19,354 |
) |
|
|
(12,868 |
) |
Financing activities: |
|
|
|
Borrowings under credit facilities |
|
70,500 |
|
|
|
- |
|
Repayments of credit facility borrowings |
|
(70,500 |
) |
|
|
(45,000 |
) |
Debt issuance costs |
|
(1,210 |
) |
|
|
- |
|
Repayments of other long-term debt |
|
(1,301 |
) |
|
|
(502 |
) |
Common stock dividends paid |
|
(7,916 |
) |
|
|
(8,017 |
) |
Issuance of common stock |
|
502 |
|
|
|
16,272 |
|
Payroll tax paid to settle shares forfeited upon vesting of
stock |
|
(1,412 |
) |
|
|
(492 |
) |
Purchase of treasury stock |
|
(6,600 |
) |
|
|
(5,741 |
) |
Cash used
for financing activities |
|
(17,937 |
) |
|
|
(43,480 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
(2,594 |
) |
|
|
955 |
|
Increase
(decrease) in cash and cash equivalents |
|
9,969 |
|
|
|
(7,958 |
) |
Cash and
cash equivalents at beginning of period |
|
40,061 |
|
|
|
51,621 |
|
Cash and
cash equivalents at end of period |
$ |
50,030 |
|
|
$ |
43,663 |
|
|
|
|
|
|
QUANEX
BUILDING PRODUCTS CORPORATION |
FREE CASH
FLOW AND NET DEBT RECONCILIATION |
(In thousands) |
(Unaudited) |
|
The following table
reconciles the Company's calculation of Free Cash Flow, a non-GAAP
measure, to its most directly comparable GAAP measure. The Company
defines Free Cash Flow as cash provided by (used for) operating
activities less capital expenditures. |
|
|
|
|
|
Three Months Ended July 31, |
|
Nine Months Ended July, 31 |
|
2022 |
|
2021 |
|
2022 |
|
2021 |
Cash provided by operating activities |
51,735 |
|
|
18,475 |
|
|
$49,854 |
|
|
$47,435 |
|
Capital
expenditures |
(5,703 |
) |
|
(6,207 |
) |
|
(19,488 |
) |
|
(16,006 |
) |
Free
Cash Flow |
$46,032 |
|
|
$12,268 |
|
|
$30,366 |
|
|
$31,429 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table
reconciles the Company's Net Debt which is defined as total debt
principal of the Company plus finance lease obligations minus
cash. |
|
|
|
|
|
|
|
|
|
|
|
|
|
As of July 31, |
|
|
|
|
|
2022 |
|
2021 |
|
|
|
|
|
|
Revolving
credit facility |
$38,000 |
|
|
$58,000 |
|
|
|
|
|
|
|
Finance
lease obligations |
20,105 |
|
|
15,951 |
|
|
|
|
|
|
|
Total
debt(1) |
58,105 |
|
|
73,951 |
|
|
|
|
|
|
|
Less: Cash
and cash equivalents |
50,030 |
|
|
43,663 |
|
|
|
|
|
|
|
Net
Debt |
$8,075 |
|
|
$30,288 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Excludes
outstanding letters of credit. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUANEX
BUILDING PRODUCTS CORPORATION |
NON-GAAP
FINANCIAL MEASURE DISCLOSURE |
(In thousands,
except per share data) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Three Months Ended |
|
Nine Months Ended |
|
Nine Months Ended |
|
Reconciliation of Adjusted Net Income and Adjusted
EPS |
|
July 31, 2022 |
|
July 31, 2021 |
|
July 31, 2022 |
|
July 31, 2021 |
|
|
|
NetIncome |
|
DilutedEPS |
|
NetIncome |
|
DilutedEPS |
|
NetIncome |
|
DilutedEPS |
|
NetIncome |
|
DilutedEPS |
|
Net income as reported |
|
$ |
25,908 |
|
|
$ |
0.78 |
|
|
$ |
13,679 |
|
|
$ |
0.41 |
|
|
$ |
63,669 |
|
|
$ |
1.91 |
|
|
$ |
36,082 |
|
|
$ |
1.08 |
|
|
Net income
reconciling items from below |
|
257 |
|
|
$ |
0.01 |
|
|
512 |
|
|
$ |
0.01 |
|
|
291 |
|
|
$ |
0.01 |
|
|
1,686 |
|
|
$ |
0.05 |
|
|
Adjusted net
income and adjusted EPS |
|
$ |
26,165 |
|
|
$ |
0.79 |
|
|
$ |
14,191 |
|
|
$ |
0.42 |
|
|
$ |
63,960 |
|
|
$ |
1.92 |
|
|
$ |
37,768 |
|
|
$ |
1.13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of Adjusted EBITDA |
|
Three Months EndedJuly 31, 2022 |
|
Three Months EndedJuly 31, 2021 |
|
Nine Months EndedJuly 31, 2022 |
|
Nine Months EndedJuly 31, 2021 |
|
|
|
Reconciliation |
|
|
|
|
Reconciliation |
|
|
|
|
Reconciliation |
|
|
|
|
Reconciliation |
|
|
|
|
Net income
as reported |
|
$ |
25,908 |
|
|
|
|
|
$ |
13,679 |
|
|
|
|
|
$ |
63,669 |
|
|
|
|
|
$ |
36,082 |
|
|
|
|
|
Income tax
expense |
|
7,801 |
|
|
|
|
|
7,474 |
|
|
|
|
|
18,098 |
|
|
|
|
|
17,352 |
|
|
|
|
|
Other,
net |
|
(398 |
) |
|
|
|
|
(188 |
) |
|
|
|
|
(905 |
) |
|
|
|
|
(645 |
) |
|
|
|
|
Interest
expense |
|
724 |
|
|
|
|
|
597 |
|
|
|
|
|
1,849 |
|
|
|
|
|
1,988 |
|
|
|
|
|
Depreciation
and amortization |
|
9,734 |
|
|
|
|
|
10,683 |
|
|
|
|
|
30,554 |
|
|
|
|
|
32,543 |
|
|
|
|
|
EBITDA |
|
43,769 |
|
|
|
|
|
32,245 |
|
|
|
|
|
113,265 |
|
|
|
|
|
87,320 |
|
|
|
|
|
EBITDA
reconciling items from below |
|
419 |
|
|
|
|
|
682 |
|
|
|
|
|
550 |
|
|
|
|
|
2,160 |
|
|
|
|
|
Adjusted
EBITDA |
|
$ |
44,188 |
|
|
|
|
|
$ |
32,927 |
|
|
|
|
|
$ |
113,815 |
|
|
|
|
|
$ |
89,480 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciling Items |
|
Three Months EndedJuly 31, 2022 |
|
Three Months EndedJuly 31, 2021 |
|
Nine Months EndedJuly 31, 2022 |
|
Nine Months EndedJuly 31, 2021 |
|
|
|
Income Statement |
|
Reconciling Items |
|
Income Statement |
|
Reconciling Items |
|
Income Statement |
|
Reconciling Items |
|
Income Statement |
|
Reconciling Items |
|
Net
sales |
|
$ |
324,037 |
|
|
$ - |
|
|
$ |
279,877 |
|
|
$ - |
|
|
$ |
913,970 |
|
|
$ - |
|
|
$ |
780,381 |
|
|
$ - |
|
|
Cost of
sales |
|
251,446 |
|
|
- |
|
|
219,866 |
|
|
(307 |
) |
(1) |
712,931 |
|
|
- |
|
|
604,723 |
|
|
(307 |
) |
(1) |
Selling,
general and administrative |
|
28,822 |
|
|
(419 |
) |
(2) |
27,766 |
|
|
(375 |
) |
(2) |
87,774 |
|
|
(550 |
) |
(2) |
88,299 |
|
|
(1,814 |
) |
(2) |
Restructuring charges |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|
39 |
|
|
(39 |
) |
(3) |
EBITDA |
|
43,769 |
|
|
419 |
|
|
32,245 |
|
|
682 |
|
|
113,265 |
|
|
550 |
|
|
87,320 |
|
|
2,160 |
|
|
Depreciation
and amortization |
|
9,734 |
|
|
- |
|
|
10,683 |
|
|
- |
|
|
30,554 |
|
|
- |
|
|
32,543 |
|
|
- |
|
|
Operating
income |
|
34,035 |
|
|
419 |
|
|
21,562 |
|
|
682 |
|
|
82,711 |
|
|
550 |
|
|
54,777 |
|
|
2,160 |
|
|
Interest
expense |
|
(724 |
) |
|
- |
|
|
(597 |
) |
|
- |
|
|
(1,849 |
) |
|
- |
|
|
(1,988 |
) |
|
- |
|
|
Other,
net |
|
398 |
|
|
(82 |
) |
(4) |
188 |
|
|
79 |
|
(4) |
905 |
|
|
(164 |
) |
(4) |
645 |
|
|
161 |
|
(4) |
Income
before income taxes |
|
33,709 |
|
|
337 |
|
|
21,153 |
|
|
761 |
|
|
81,767 |
|
|
386 |
|
|
53,434 |
|
|
2,321 |
|
|
Income tax
expense |
|
(7,801 |
) |
|
(80 |
) |
(5) |
(7,474 |
) |
|
(249 |
) |
(5) |
(18,098 |
) |
|
(95 |
) |
(5) |
(17,352 |
) |
|
(635 |
) |
(5) |
Net
income |
|
$ |
25,908 |
|
|
$ |
257 |
|
|
$ |
13,679 |
|
|
$ |
512 |
|
|
$ |
63,669 |
|
|
$ |
291 |
|
|
$ |
36,082 |
|
|
$ |
1,686 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
earnings per share |
|
$ |
0.78 |
|
|
|
|
|
$ |
0.41 |
|
|
|
|
|
$ |
1.91 |
|
|
|
|
|
$ |
1.08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Loss on damage to
a plant caused by flooding. |
(2) Transaction and
advisory fees, loss on the sale of a plant. |
(3) Restructuring
charges related to the closure of manufacturing plant
facilities. |
(4) Foreign currency
transaction (gains) losses. |
(5) Impact on a with
and without basis. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUANEX
BUILDING PRODUCTS CORPORATION |
SELECTED
SEGMENT DATA |
(In thousands) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
This table provides
gross margin, operating (loss) income, EBITDA, and Adjusted EBITDA
by reportable segment. Non-operating expense and income tax expense
are not allocated to the reportable segments. |
|
|
NA Fenestration |
|
EU Fenestration |
|
NA Cabinet Components |
|
Unallocated Corp & Other |
|
Total |
Three months ended July 31, 2022 |
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
184,744 |
|
|
$ |
67,613 |
|
|
$ |
72,480 |
|
|
$ |
(800 |
) |
|
$ |
324,037 |
|
Cost of sales |
|
|
142,970 |
|
|
|
47,212 |
|
|
|
61,543 |
|
|
|
(279 |
) |
|
|
251,446 |
|
Gross Margin |
|
|
41,774 |
|
|
|
20,401 |
|
|
|
10,937 |
|
|
|
(521 |
) |
|
|
72,591 |
|
Gross Margin % |
|
|
22.6 |
% |
|
|
30.2 |
% |
|
|
15.1 |
% |
|
|
|
|
22.4 |
% |
Selling, general and administrative |
|
|
14,644 |
|
|
|
8,256 |
|
|
|
5,335 |
|
|
|
587 |
|
|
|
28,822 |
|
Depreciation and amortization |
|
|
4,044 |
|
|
|
2,327 |
|
|
|
3,273 |
|
|
|
90 |
|
|
|
9,734 |
|
Operating income (loss) |
|
|
23,086 |
|
|
|
9,818 |
|
|
|
2,329 |
|
|
|
(1,198 |
) |
|
|
34,035 |
|
Depreciation and amortization |
|
|
4,044 |
|
|
|
2,327 |
|
|
|
3,273 |
|
|
|
90 |
|
|
|
9,734 |
|
EBITDA |
|
|
27,130 |
|
|
|
12,145 |
|
|
|
5,602 |
|
|
|
(1,108 |
) |
|
|
43,769 |
|
Transaction and advisory fees |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
419 |
|
|
|
419 |
|
Adjusted EBITDA |
|
$ |
27,130 |
|
|
$ |
12,145 |
|
|
$ |
5,602 |
|
|
$ |
(689 |
) |
|
$ |
44,188 |
|
Adjusted EBITDA Margin % |
|
|
14.7 |
% |
|
|
18.0 |
% |
|
|
7.7 |
% |
|
|
|
|
13.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
Three months ended July 31, 2021 |
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
147,818 |
|
|
$ |
71,114 |
|
|
$ |
61,936 |
|
|
$ |
(991 |
) |
|
$ |
279,877 |
|
Cost of sales |
|
|
116,517 |
|
|
|
49,479 |
|
|
|
54,334 |
|
|
|
(464 |
) |
|
|
219,866 |
|
Gross Margin |
|
|
31,301 |
|
|
|
21,635 |
|
|
|
7,602 |
|
|
|
(527 |
) |
|
|
60,011 |
|
Gross Margin % |
|
|
21.2 |
% |
|
|
30.4 |
% |
|
|
12.3 |
% |
|
|
|
|
21.4 |
% |
Selling, general and administrative |
|
|
13,428 |
|
|
|
7,525 |
|
|
|
5,130 |
|
|
|
1,683 |
|
|
|
27,766 |
|
Depreciation and amortization |
|
|
4,571 |
|
|
|
2,646 |
|
|
|
3,390 |
|
|
|
76 |
|
|
|
10,683 |
|
Operating income (loss) |
|
|
13,302 |
|
|
|
11,464 |
|
|
|
(918 |
) |
|
|
(2,286 |
) |
|
|
21,562 |
|
Depreciation and amortization |
|
|
4,571 |
|
|
|
2,646 |
|
|
|
3,390 |
|
|
|
76 |
|
|
|
10,683 |
|
EBITDA |
|
|
17,873 |
|
|
|
14,110 |
|
|
|
2,472 |
|
|
|
(2,210 |
) |
|
|
32,245 |
|
Loss on the damage of a plant |
|
|
- |
|
|
|
307 |
|
|
|
- |
|
|
|
- |
|
|
|
307 |
|
Loss on sale of plant |
|
|
375 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
375 |
|
Adjusted EBITDA |
|
$ |
18,248 |
|
|
$ |
14,417 |
|
|
$ |
2,472 |
|
|
$ |
(2,210 |
) |
|
$ |
32,927 |
|
Adjusted EBITDA Margin % |
|
|
12.3 |
% |
|
|
20.3 |
% |
|
|
4.0 |
% |
|
|
|
|
11.8 |
% |
|
|
|
|
|
|
|
|
|
|
|
Nine
months ended July 31, 2022 |
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
509,283 |
|
|
$ |
199,954 |
|
|
$ |
207,711 |
|
|
$ |
(2,978 |
) |
|
$ |
913,970 |
|
Cost of sales |
|
|
396,505 |
|
|
|
138,147 |
|
|
|
179,791 |
|
|
|
(1,512 |
) |
|
|
712,931 |
|
Gross Margin |
|
|
112,778 |
|
|
|
61,807 |
|
|
|
27,920 |
|
|
|
(1,466 |
) |
|
|
201,039 |
|
Gross Margin % |
|
|
22.1 |
% |
|
|
30.9 |
% |
|
|
13.4 |
% |
|
|
|
|
22.0 |
% |
Selling, general and administrative |
|
|
43,099 |
|
|
|
24,160 |
|
|
|
15,823 |
|
|
|
4,692 |
|
|
|
87,774 |
|
Depreciation and amortization |
|
|
12,221 |
|
|
|
7,418 |
|
|
|
10,653 |
|
|
|
262 |
|
|
|
30,554 |
|
Operating income (loss) |
|
|
57,458 |
|
|
|
30,229 |
|
|
|
1,444 |
|
|
|
(6,420 |
) |
|
|
82,711 |
|
Depreciation and amortization |
|
|
12,221 |
|
|
|
7,418 |
|
|
|
10,653 |
|
|
|
262 |
|
|
|
30,554 |
|
EBITDA |
|
|
69,679 |
|
|
|
37,647 |
|
|
|
12,097 |
|
|
|
(6,158 |
) |
|
|
113,265 |
|
Transaction and advisory fees |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
550 |
|
|
|
550 |
|
Adjusted EBITDA |
|
$ |
69,679 |
|
|
$ |
37,647 |
|
|
$ |
12,097 |
|
|
$ |
(5,608 |
) |
|
$ |
113,815 |
|
Adjusted EBITDA Margin % |
|
|
13.7 |
% |
|
|
18.8 |
% |
|
|
5.8 |
% |
|
|
|
|
12.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
Nine
months ended July 31, 2021 |
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
422,077 |
|
|
$ |
181,862 |
|
|
$ |
179,492 |
|
|
$ |
(3,050 |
) |
|
$ |
780,381 |
|
Cost of sales |
|
|
328,278 |
|
|
|
122,631 |
|
|
|
155,370 |
|
|
|
(1,556 |
) |
|
|
604,723 |
|
Gross Margin |
|
|
93,799 |
|
|
|
59,231 |
|
|
|
24,122 |
|
|
|
(1,494 |
) |
|
|
175,658 |
|
Gross Margin % |
|
|
22.2 |
% |
|
|
32.6 |
% |
|
|
13.4 |
% |
|
|
|
|
22.5 |
% |
Selling, general and administrative |
|
|
38,944 |
|
|
|
21,559 |
|
|
|
15,372 |
|
|
|
12,424 |
|
|
|
88,299 |
|
Restructuring charges |
|
|
39 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
39 |
|
Depreciation and amortization |
|
|
14,528 |
|
|
|
7,771 |
|
|
|
9,965 |
|
|
|
279 |
|
|
|
32,543 |
|
Operating income (loss) |
|
|
40,288 |
|
|
|
29,901 |
|
|
|
(1,215 |
) |
|
|
(14,197 |
) |
|
|
54,777 |
|
Depreciation and amortization |
|
|
14,528 |
|
|
|
7,771 |
|
|
|
9,965 |
|
|
|
279 |
|
|
|
32,543 |
|
EBITDA |
|
|
54,816 |
|
|
|
37,672 |
|
|
|
8,750 |
|
|
|
(13,918 |
) |
|
|
87,320 |
|
Loss on the damage of a plant |
|
|
- |
|
|
|
307 |
|
|
|
- |
|
|
|
- |
|
|
|
307 |
|
Loss on sale of plant |
|
|
375 |
|
|
|
- |
|
|
|
- |
|
|
|
1,439 |
|
|
|
1,814 |
|
Restructuring charges |
|
|
39 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
39 |
|
Adjusted EBITDA |
|
$ |
55,230 |
|
|
$ |
37,979 |
|
|
$ |
8,750 |
|
|
$ |
(12,479 |
) |
|
$ |
89,480 |
|
Adjusted EBITDA Margin % |
|
|
13.1 |
% |
|
|
20.9 |
% |
|
|
4.9 |
% |
|
|
|
|
11.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
QUANEX
BUILDING PRODUCTS CORPORATION |
SALES
ANALYSIS |
(In thousands) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended July 31, |
|
Nine Months Ended July, 31 |
|
|
2022 |
|
2021 |
|
2022 |
|
2021 |
|
|
|
|
|
|
|
|
|
NA Fenestration: |
|
|
|
|
|
|
|
|
United States - fenestration |
$ |
162,215 |
|
|
$ |
129,291 |
|
|
$ |
447,425 |
|
|
$ |
369,809 |
|
|
International - fenestration |
|
10,722 |
|
|
|
9,581 |
|
|
|
30,952 |
|
|
|
25,756 |
|
|
United
States - non-fenestration |
|
8,324 |
|
|
|
5,853 |
|
|
|
22,117 |
|
|
|
17,543 |
|
|
International - non-fenestration |
|
3,483 |
|
|
|
3,093 |
|
|
|
8,789 |
|
|
|
8,969 |
|
|
|
$ |
184,744 |
|
|
$ |
147,818 |
|
|
$ |
509,283 |
|
|
$ |
422,077 |
|
EU Fenestration:(1) |
|
|
|
|
|
|
|
|
International - fenestration |
$ |
49,041 |
|
|
$ |
54,883 |
|
|
$ |
148,525 |
|
|
$ |
147,072 |
|
|
International - non-fenestration |
|
18,572 |
|
|
|
16,231 |
|
|
|
51,429 |
|
|
|
34,790 |
|
|
|
$ |
67,613 |
|
|
$ |
71,114 |
|
|
$ |
199,954 |
|
|
$ |
181,862 |
|
NA Cabinet Components: |
|
|
|
|
|
|
|
|
United
States - fenestration |
$ |
4,857 |
|
|
$ |
3,240 |
|
|
$ |
13,288 |
|
|
$ |
9,711 |
|
|
United
States - non-fenestration |
|
66,758 |
|
|
|
57,418 |
|
|
|
191,908 |
|
|
|
168,308 |
|
|
International - non-fenestration |
|
865 |
|
|
|
1,278 |
|
|
|
2,515 |
|
|
|
1,473 |
|
|
|
$ |
72,480 |
|
|
$ |
61,936 |
|
|
$ |
207,711 |
|
|
$ |
179,492 |
|
Unallocated Corporate & Other: |
|
|
|
|
|
|
|
|
Eliminations |
$ |
(800 |
) |
|
$ |
(991 |
) |
|
$ |
(2,978 |
) |
|
$ |
(3,050 |
) |
|
|
$ |
(800 |
) |
|
$ |
(991 |
) |
|
$ |
(2,978 |
) |
|
$ |
(3,050 |
) |
|
|
|
|
|
|
|
|
|
Net Sales |
$ |
324,037 |
|
|
$ |
279,877 |
|
|
$ |
913,970 |
|
|
$ |
780,381 |
|
|
|
|
|
|
|
|
|
|
(1) Reflects reduction
of $8.9 million and $11.7 million in revenue associated with
foreign currency exchange rate impacts for the three and nine
months ended July 31, 2022, respectively. |
|
|
|
|
|
|
|
|
|
Quanex (NYSE:NX)
過去 株価チャート
から 6 2024 まで 7 2024
Quanex (NYSE:NX)
過去 株価チャート
から 7 2023 まで 7 2024